3rd Annual “Big Four” Pharmaceutical Pricing Boot Camp

Monday, May 18, 2009

About

The U.S. government spends billions of dollars per year on the purchase of drugs making it one of the largest purchasers of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company’s total revenue, and a company cannot remain competitive in today’s market without selling to the government. As pharmaceutical manufacturers’ revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs.

While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of “Big Four” pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned pricing practitioner baffled. On top of complying with the “Big Four’s” numerous rules and regulations, companies must also evaluate how their “Big Four” prices affect their overall pricing.

Master the essentials of key “Big Four” pricing concepts and methodologies

ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies. ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies. Also hear the latest information on legislative proposals/changes that may impact the 340B program and TRICARE rebates.

 

Contents & Contributors

About

The U.S. government spends billions of dollars per year on the purchase of drugs making it one of the largest purchasers of pharmaceuticals in the U.S. Sales to the government typically account for a large portion of a company’s total revenue, and a company cannot remain competitive in today’s market without selling to the government. As pharmaceutical manufacturers’ revenue and profits are so closely tied to government contracts and pricing, it is essential to have a thorough understanding of the Veterans Health Care Act, Federal Supply Schedule Contracting, Federal Ceiling Price, and pharmacy benefits programs.

While having the government as a client is lucrative, it can be costly, time consuming and confusing. Understanding the basics and key terms of “Big Four” pricing is necessary to ensure that companies do not enter into price contracts that obligate them to comply with impossible terms. Selling to the VA, DoD, PHS and Coast Guard also requires constant price calculations and price reporting. These calculations are often perplexing and result in price anomalies that can leave even the most seasoned pricing practitioner baffled. On top of complying with the “Big Four’s” numerous rules and regulations, companies must also evaluate how their “Big Four” prices affect their overall pricing.

Master the essentials of key “Big Four” pricing concepts and methodologies

ACI’s “Big Four” Pharmaceutical Pricing Boot Camp has been designed to give novices and experienced practitioners alike a complete understanding of core pricing competencies. ACI has assembled a faculty of the government authorities on “Big Four” pricing and pharmacy benefits programs along with expert pricing practitioners. This distinguished faculty will make sense of complicated terminology and pricing calculations and teach you how to navigate the complexities of working with the “Big Four” agencies. Also hear the latest information on legislative proposals/changes that may impact the 340B program and TRICARE rebates.

 

Contents & Contributors

Overview of the “Big Four” and the Veterans Health Care Act (VHCA)
Melbourne A. Noel, Jr., Department of Veteran Affairs
Marci Anderson, VA Office of Inspector General, Office of Contract Review

VHCA §603: Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
Joy E. Sturm, Hogan & Hartson LLP
Marci Anderson, VA Office of Inspector General, Office of Contract Review
Melbourne A. Noel, Jr., Department of Veteran Affairs
John D. Shakow, King & Spalding

FSS Contracting for the Pharmaceutical Industry: Exploring the Federal Supply Schedule
Maureen Regan, VA Office of Inspector General

Interacting With the VA and Understanding the Agency’s Structure
Maureen Regan, VA Office of Inspector General
Marci Anderson, VA Office of Inspector General, Office of Contract Review

Effectively Managing the Negotiation Process
W. R. (Bob) Satterfield, III, VA Office of Acquisition & Logistics
Christine A. Szrom, VA Office of Acquisition & Logistics

Government fss Programs
Marci Anderson, VA Office of Inspector General, Office of Contract Review
Maureen Regan, VA Office of Inspector General
Merle M. DeLancey Dickstein Shapiro LLP

Single versus Dual Pricing
Marci Anderson, VA Office of Inspector General, Office of Contract Review

Background to the New TRICARE Rule
Melbourne A. Noel, Jr., Department of Veteran Affairs

TRICARE Rx Program
Carol Cooper, TRICARE Management Activity

TRICARE: A Study in the DoD’s Managed Health Care Benefits Program and Update on TRICARE Rebates
Constance A. Wilkinson, Epstein Becker & Green, P.C.

340B Program Fundamentals
Debjit A. Ghosh, Huron Consulting Group
Benjamin S. Martin, Epstein Becker & Green, P.C.
William von Oehsen, Safety Net Hospitals for Pharmaceutical Access

Demystifying the DoD Uniform Formulary
Allison D. Pugsley, Hogan & Hartson LLP, VA formulary management
Vincent Calabrese, Pharmacy Benefits Management Services

Strategies for Securing National Contracts and Blanket Purchase Agreements
Steven A. Thomas, Department of Veterans Affairs

All new all improved? bpa’s & national contracts;
Larry Allen, Coalition for Government Procurement

Audit Rights, Record Retention and Penalties
Maureen Regan, VA Office of Inspector General
T. Reed Stephens, McDermott Will & Emery LLC



DOCUMENT TYPES: PPT PPTX PRESENTATIONS AVAILABLE: 15

7:15
Registration and Continental Breakfast
8:15
Co-Chairs' Opening Remarks
Mr. Marcus Farbstein
Director‚ Government Affairs
Genentech
Ms. Joy E. Sturm
Partner
Hogan Lovells
8:30
Overview of the "Big Four" and the Veterans Health Care Act (VHCA)
Marci Anderson
Senior Auditor
VA Office of Inspector General, Office of Contract Review
Mr. Melbourne A. Noel‚ Jr.
Strategic Consultant, Federal Contracting and Compliance
Compliance Information Services
9:45
VHCA Section 603: Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
Marci Anderson
Senior Auditor
VA Office of Inspector General, Office of Contract Review
1 file
VHCA § 603: Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
1.5 MB 92 pages Presentation
PPT - VHCA § 603:  Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
Mr. Melbourne A. Noel‚ Jr.
Strategic Consultant, Federal Contracting and Compliance
Compliance Information Services
1 file
VHCA § 603: Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
1.5 MB 92 pages Presentation
PPT - VHCA § 603:  Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
John D. Shakow
Partner
King & Spalding
1 file
VHCA § 603: Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
1.5 MB 92 pages Presentation
PPT - VHCA § 603:  Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
Ms. Joy E. Sturm
Partner
Hogan Lovells
1 file
VHCA § 603: Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
1.5 MB 92 pages Presentation
PPT - VHCA § 603:  Calculating the Non-FAMP and the Federal Ceiling Price (FCP)
11:15
Morning Coffee Break
11:30
Exploring the Federal Supply Schedule Relative to Pharmaceutical Government Contracting
Maureen Regan
Counselor to the Inspector General
VA Office of the Inspector General (Washington, DC)
1 file
FSS Contracting for the Pharmaceutical Industry Exploring the Federal Supply Schedule
94.4 KB 16 pages Presentation
PPTX - FSS Contracting for the Pharmaceutical IndustryExploring the Federal Supply Schedule
Mr. Merle M. DeLancey
Partner
Dickstein Shapiro LLP
1 file
Determining the FSS Price: Concepts and Considerations in Government FSS Programs
324 KB 45 pages Presentation
PPT - Determining the FSS Price:  Concepts and Considerations in Government FSS Programs
12:15
Networking Luncheon
13:30
Interacting With the VA and Understanding the Agency's Structure
Marci Anderson
Senior Auditor
VA Office of Inspector General, Office of Contract Review
1 file
Interacting with the VA and Understanding the Agency’s Structure
207.5 KB 30 pages Presentation
PPT - Interacting with the VA and Understanding the Agency’s Structure
Maureen Regan
Counselor to the Inspector General
VA Office of the Inspector General (Washington, DC)
1 file
Interacting with the VA and Understanding the Agency’s Structure
207.5 KB 30 pages Presentation
PPT - Interacting with the VA and Understanding the Agency’s Structure
14:15
Effectively Managing the Negotiation Process
Mr. W.R. (Bob) Satterfield
Assistant Director‚ Contracting Branch - Administration
Federal Supply Schedule Service
Ms. Christine A. Szrom
Contract Specialist‚ Federal Supply Schedule Service
National Acquisition Center‚ VA Office of Acquisition & Logistics
15:15
Afternoon Coffee Break
15:30
Determining the FSS Price: Concepts and Considerations in Government Pharmaceutical Price Discount Programs
Marci Anderson
Senior Auditor
VA Office of Inspector General, Office of Contract Review
1 file
Determining the FSS Price: Concepts and Considerations in Government FSS Programs
324 KB 45 pages Presentation
PPT - Determining the FSS Price:  Concepts and Considerations in Government FSS Programs
Maureen Regan
Counselor to the Inspector General
VA Office of the Inspector General (Washington, DC)
1 file
Determining the FSS Price: Concepts and Considerations in Government FSS Programs
324 KB 45 pages Presentation
PPT - Determining the FSS Price:  Concepts and Considerations in Government FSS Programs
Mr. Merle M. DeLancey
Partner
Dickstein Shapiro LLP
1 file
Determining the FSS Price: Concepts and Considerations in Government FSS Programs
324 KB 45 pages Presentation
PPT - Determining the FSS Price:  Concepts and Considerations in Government FSS Programs
17:15
Conference Adjourns to Day 2
7:30
Continental Breakfast
8:15
Co-Chairs' Remarks
8:30
Single Pricing vs. Dual Pricing
Marci Anderson
Senior Auditor
VA Office of Inspector General, Office of Contract Review
1 file
Single versus Dual Pricing
287.5 KB 26 pages Presentation
PPT - Single versus Dual Pricing
9:30
TRICARE: A Study in the DoD's Managed Health Care Benefits Program and Update on TRICARE Rebates
Ms. Carol Cooper
Associate General Counsel
TRICARE Management Activity
1 file
TRICARE Rx PROGRAM
566.5 KB 13 pages Presentation
PPT - TRICARE Rx PROGRAM
Ms. Constance A. Wilkinson
Member of the Firm
Epstein Becker & Green‚ P.C.
1 file
Manufacturer Perspectives on Recent Developments in TRICARE Retail Pharmacy Program
459.5 KB 13 pages Presentation
PPT - Manufacturer Perspectives on Recent Developments in TRICARE Retail Pharmacy Program
Mr. Melbourne A. Noel‚ Jr.
Strategic Consultant, Federal Contracting and Compliance
Compliance Information Services
1 file
Background to the New TRICARE Rule
161.5 KB 9 pages Presentation
PPT - Background to the New TRICARE Rule
11:00
Morning Coffee Break
11:15
Status Update on the TRICARE Rebates Litigation
Ms. Donna Lee Yesner
Partner
Morgan Lewis & Bockius LLP
11:45
Networking Luncheon
13:00
340B Program Fundamentals
Mr. Debjit A. Ghosh
Managing Director
Huron Consulting Group
1 file
340B Program Fundamentals
423 KB 38 pages Presentation
PPT - 340B Program Fundamentals
Mr. Benjamin S. Martin
Member of the Firm
Epstein Becker & Green‚ P.C.
1 file
340B Program Fundamentals
423 KB 38 pages Presentation
PPT - 340B Program Fundamentals
-Mr. William von Oehsen
President and General Counsel, Safety Net Hospitals for Pharmaceutical Access &
Principal, Powers Pyles Sutter & Verville PC
2 files
340B Program Fundamentals
423 KB 38 pages Presentation
PPT - 340B Program Fundamentals
INSIGHTS INTO 340B LEGISLATIVE, REGULATORY AND LITIGATION CHANGES THAT WILL IMPACT ALL PRICING STAKEHOLDERS
543.5 KB 27 pages Presentation
PPT - INSIGHTS INTO 340B LEGISLATIVE, REGULATORY AND LITIGATION CHANGES THAT WILL IMPACT ALL PRICING STAKEHOLDERS
Ms. Joy E. Sturm
Partner
Hogan Lovells
14:15
Demystifying the National Formulary System
Mr. Vincent Calabrese
Associate Chief Consultant
Pharmacy Benefits Management
1 file
VA Formulary Management
697.5 KB 36 pages Presentation
PPT - VA Formulary Management
Ms. Allison Pugsley
Attorney
Hogan Lovells
1 file
Demystifying the DoD Uniform Formulary
805 KB 25 pages Presentation
PPT - Demystifying the DoD Uniform Formulary
Mr. Melbourne A. Noel‚ Jr.
Strategic Consultant, Federal Contracting and Compliance
Compliance Information Services
15:15
Afternoon Coffee Break
15:30
Strategies for Securing National Contracts and Blanket Purchase Agreements
Mr. Steven A. Thomas
Director‚ National Contract Service
Department of Veterans Affairs
1 file
“Big Four” Pharmaceutical Pricing Boot Camp Briefing
218.2 KB 20 pages Presentation
PPTX - “Big Four” Pharmaceutical Pricing Boot Camp Briefing
Mr. Larry Allen
Executive Vice President
Coalition for Government Procurement
1 file
ALL NEW ALL IMPROVED? BPA’S & NATIONAL CONTRACTS
304 KB 17 pages Presentation
PPT - ALL NEWALL IMPROVED?BPA’S & NATIONAL CONTRACTS
16:30
Audit Rights‚ Record Retention and Penalties
Maureen Regan
Counselor to the Inspector General
VA Office of the Inspector General (Washington, DC)
1 file
Audit Rights, Record Retention, and Penalties
674 KB 39 pages Presentation
PPT - Audit Rights, Record Retention, and Penalties
Mr. Reed Stephens
Partner
McDermott Will & Emery LLP
1 file
Audit Rights, Record Retention, and Penalties
674 KB 39 pages Presentation
PPT - Audit Rights, Record Retention, and Penalties
17:15
Conference Concludes